TY - JOUR
T1 - The role of leukocyte counts in patients with unstable angina pectoris or myocardial infarction; prognostic significance and correlation with plasma brain natriuretic peptide (BNP) levels
AU - Akhtar, Naveed
AU - Adil, Malik Muhammad
AU - Ahmed, Waqas
AU - Habib-ur-Rehman,
AU - Shah, Mumtaz Ali
PY - 2011/1
Y1 - 2011/1
N2 - Objective: To study the role of leukocyte count in patients with unstable angina pectoris or myocardial infarction (Acute Coronary Syndrome) its prognostic significance and correlation with plasma brain natriuretic peptide (BNP) levels. Methods: A total of 143 Patients with unstable angina pectoris, non-ST segment elevation MI and ST segment elevation MI were considered for entry into the study. Plasma BNP levels were measured using a commercial BNP kit (AxSym System BNP Reagent Pack, Abbott Laboratories, Abbott Park, IL, USA). Leukocyte count was measured on CELL DYNE counter of Abbott Laboratories. Results: Mean age of the patients were 58.67±12.48 years. Mean leukocyte count was 9772±3006 /cumm. In all 43 (30 %) patients had high leukocyte count, and 82 (57%) patients had elevated BNP level. Out of 61 patients with normal BNP level, 49 (80%) had normal leukocyte count and 12 (20%) had elevated leukocyte count. Out of 82 patients with elevated BNP level, 51 (62%) had normal leukocyte count and 31 (38%) had elevated leukocyte count (P = 0.01). Conclusion: No statistically significant association was found between Leukocyte count and ACS. Although there is a trend of increased Leukocyte count noted in patients with increase BNP level. This finding necessitates further studies to elucidate its accurate significance.
AB - Objective: To study the role of leukocyte count in patients with unstable angina pectoris or myocardial infarction (Acute Coronary Syndrome) its prognostic significance and correlation with plasma brain natriuretic peptide (BNP) levels. Methods: A total of 143 Patients with unstable angina pectoris, non-ST segment elevation MI and ST segment elevation MI were considered for entry into the study. Plasma BNP levels were measured using a commercial BNP kit (AxSym System BNP Reagent Pack, Abbott Laboratories, Abbott Park, IL, USA). Leukocyte count was measured on CELL DYNE counter of Abbott Laboratories. Results: Mean age of the patients were 58.67±12.48 years. Mean leukocyte count was 9772±3006 /cumm. In all 43 (30 %) patients had high leukocyte count, and 82 (57%) patients had elevated BNP level. Out of 61 patients with normal BNP level, 49 (80%) had normal leukocyte count and 12 (20%) had elevated leukocyte count. Out of 82 patients with elevated BNP level, 51 (62%) had normal leukocyte count and 31 (38%) had elevated leukocyte count (P = 0.01). Conclusion: No statistically significant association was found between Leukocyte count and ACS. Although there is a trend of increased Leukocyte count noted in patients with increase BNP level. This finding necessitates further studies to elucidate its accurate significance.
KW - BNP
KW - Coronary artery disease
KW - Leukocyte count
UR - http://www.scopus.com/inward/record.url?scp=78651229415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78651229415&partnerID=8YFLogxK
M3 - Article
C2 - 22368903
AN - SCOPUS:78651229415
SN - 0030-9982
VL - 61
SP - 51
EP - 54
JO - JPMA. The Journal of the Pakistan Medical Association
JF - JPMA. The Journal of the Pakistan Medical Association
IS - 1
ER -